Cargando…

High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction

BACKGROUND: Immunosuppression is an important factor in the incidence of infections in transplant recipient. Few studies are available on the management of immunosuppression (IS) treatment in the liver transplant (LT) recipients complicated with infection. The aim of this study is to describe our ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fang, Pang, Xiao-Yun, Shen, Chuan, Han, Long-Zhi, Deng, Yu-Xiao, Chen, Xiao-Song, Zhang, Jian-Jun, Xia, Qiang, Qian, Yong-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723669/
https://www.ncbi.nlm.nih.gov/pubmed/33362376
http://dx.doi.org/10.3748/wjg.v26.i45.7191
_version_ 1783620391050149888
author Chen, Fang
Pang, Xiao-Yun
Shen, Chuan
Han, Long-Zhi
Deng, Yu-Xiao
Chen, Xiao-Song
Zhang, Jian-Jun
Xia, Qiang
Qian, Yong-Bing
author_facet Chen, Fang
Pang, Xiao-Yun
Shen, Chuan
Han, Long-Zhi
Deng, Yu-Xiao
Chen, Xiao-Song
Zhang, Jian-Jun
Xia, Qiang
Qian, Yong-Bing
author_sort Chen, Fang
collection PubMed
description BACKGROUND: Immunosuppression is an important factor in the incidence of infections in transplant recipient. Few studies are available on the management of immunosuppression (IS) treatment in the liver transplant (LT) recipients complicated with infection. The aim of this study is to describe our experience in the management of IS treatment during bacterial bloodstream infection (BSI) in LT recipients and assess the effect of temporary IS withdrawal on 30 d mortality of recipients presenting with severe infection. AIM: To assess the effect of temporary IS withdrawal on 30 d mortality of LT recipients presenting with severe infection. METHODS: A retrospective study was conducted with patients diagnosed with BSI after LT in the Department of Liver Surgery, Renji Hospital from January 1, 2016 through December 31, 2017. All recipients diagnosed with BSI after LT were included. Univariate and multivariate Cox regression analysis of risk factors for 30 d mortality was conducted in the LT recipients with Gram-negative bacterial (GNB) infection. RESULTS: Seventy-four episodes of BSI were identified in 70 LT recipients, including 45 episodes of Gram-positive bacterial (GPB) infections in 42 patients and 29 episodes of GNB infections in 28 patients. Overall, IS reduction (at least 50% dose reduction or cessation of one or more immunosuppressive agent) was made in 28 (41.2%) cases, specifically, in 5 (11.9%) cases with GPB infections and 23 (82.1%) cases with GNB infections. The 180 d all-cause mortality rate was 18.5% (13/70). The mortality rate in GNB group (39.3%, 11/28) was significantly higher than that in GPB group (4.8%, 2/42) (P = 0.001). All the deaths in GNB group were attributed to worsening infection secondary to IS withdrawal, but the deaths in GPB group were all due to graft-versus-host disease. GNB group was associated with significantly higher incidence of intra-abdominal infection, IS reduction, and complete IS withdrawal than GPB group (P < 0.05). Cox regression showed that rejection (adjusted hazard ratio 7.021, P = 0.001) and complete IS withdrawal (adjusted hazard ratio 12.65, P = 0.019) were independent risk factors for 30 d mortality in patients with GNB infections after LT. CONCLUSION: IS reduction is more frequently associated with GNB infection than GPB infection in LT recipients. Complete IS withdrawal should be cautious due to increased risk of mortality in LT recipients complicated with BSI. IS:
format Online
Article
Text
id pubmed-7723669
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-77236692020-12-24 High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction Chen, Fang Pang, Xiao-Yun Shen, Chuan Han, Long-Zhi Deng, Yu-Xiao Chen, Xiao-Song Zhang, Jian-Jun Xia, Qiang Qian, Yong-Bing World J Gastroenterol Retrospective Cohort Study BACKGROUND: Immunosuppression is an important factor in the incidence of infections in transplant recipient. Few studies are available on the management of immunosuppression (IS) treatment in the liver transplant (LT) recipients complicated with infection. The aim of this study is to describe our experience in the management of IS treatment during bacterial bloodstream infection (BSI) in LT recipients and assess the effect of temporary IS withdrawal on 30 d mortality of recipients presenting with severe infection. AIM: To assess the effect of temporary IS withdrawal on 30 d mortality of LT recipients presenting with severe infection. METHODS: A retrospective study was conducted with patients diagnosed with BSI after LT in the Department of Liver Surgery, Renji Hospital from January 1, 2016 through December 31, 2017. All recipients diagnosed with BSI after LT were included. Univariate and multivariate Cox regression analysis of risk factors for 30 d mortality was conducted in the LT recipients with Gram-negative bacterial (GNB) infection. RESULTS: Seventy-four episodes of BSI were identified in 70 LT recipients, including 45 episodes of Gram-positive bacterial (GPB) infections in 42 patients and 29 episodes of GNB infections in 28 patients. Overall, IS reduction (at least 50% dose reduction or cessation of one or more immunosuppressive agent) was made in 28 (41.2%) cases, specifically, in 5 (11.9%) cases with GPB infections and 23 (82.1%) cases with GNB infections. The 180 d all-cause mortality rate was 18.5% (13/70). The mortality rate in GNB group (39.3%, 11/28) was significantly higher than that in GPB group (4.8%, 2/42) (P = 0.001). All the deaths in GNB group were attributed to worsening infection secondary to IS withdrawal, but the deaths in GPB group were all due to graft-versus-host disease. GNB group was associated with significantly higher incidence of intra-abdominal infection, IS reduction, and complete IS withdrawal than GPB group (P < 0.05). Cox regression showed that rejection (adjusted hazard ratio 7.021, P = 0.001) and complete IS withdrawal (adjusted hazard ratio 12.65, P = 0.019) were independent risk factors for 30 d mortality in patients with GNB infections after LT. CONCLUSION: IS reduction is more frequently associated with GNB infection than GPB infection in LT recipients. Complete IS withdrawal should be cautious due to increased risk of mortality in LT recipients complicated with BSI. IS: Baishideng Publishing Group Inc 2020-12-07 2020-12-07 /pmc/articles/PMC7723669/ /pubmed/33362376 http://dx.doi.org/10.3748/wjg.v26.i45.7191 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Cohort Study
Chen, Fang
Pang, Xiao-Yun
Shen, Chuan
Han, Long-Zhi
Deng, Yu-Xiao
Chen, Xiao-Song
Zhang, Jian-Jun
Xia, Qiang
Qian, Yong-Bing
High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
title High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
title_full High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
title_fullStr High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
title_full_unstemmed High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
title_short High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
title_sort high mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723669/
https://www.ncbi.nlm.nih.gov/pubmed/33362376
http://dx.doi.org/10.3748/wjg.v26.i45.7191
work_keys_str_mv AT chenfang highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT pangxiaoyun highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT shenchuan highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT hanlongzhi highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT dengyuxiao highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT chenxiaosong highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT zhangjianjun highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT xiaqiang highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction
AT qianyongbing highmortalityassociatedwithgramnegativebacterialbloodstreaminfectioninlivertransplantrecipientsundergoingimmunosuppressionreduction